Patisiran

Patisiran Overview

Patisiran, sold under the brand name Onpattro, is a medication for the treatment of polyneuropathy in people with hereditary transthyretin-mediated amyloidosis. Hereditary transthyretin-mediated amyloidosis is a fatal rare disease that is estimated to affect 50,000 people worldwide.[1] It is the first small interfering RNA-based drug approved by the U.S. Food and Drug Administration (FDA) and the first drug approved by the FDA to treat this condition.[1] It is ...

Read more Patisiran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Patisiran

Recent Patisiran Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Patisiran

Injection: 2mg/ml
Solution: 10mg/5ml (2mg/ml)

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Patisiran or a similar ingredient: (1 result)

ONPATTRO Patisiran